Literature DB >> 24759722

Comparison of ESwab with traditional swabs for detection of methicillin-resistant Staphylococcus aureus using two different walk-away commercial real-time PCR methods.

Suzane Silbert1, Carly Kubasek2, Dominic Uy2, Raymond Widen2.   

Abstract

The ESwab system (Copan Diagnostics) was evaluated as a nasopharyngeal specimen collection device to be used for methicillin-resistant Staphylococcus aureus (MRSA) detection by the GeneXpert and BD Max MRSA assays. Different MRSA strains and dilutions of each strain were tested in triplicate. ESwabs proved to be a suitable collection system for the two assays tested.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24759722      PMCID： PMC4097676          DOI： 10.1128/JCM.00315-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

2.  Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands.

Authors:  M J C A van Trijp; D C Melles; W D H Hendriks; G A Parlevliet; M Gommans; A Ott
Journal:  Infect Control Hosp Epidemiol       Date:  2007-06-19       Impact factor: 3.254

3.  Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability.

Authors:  Kenneth G Van Horn; Carol D Audette; Denise Sebeck; Kelly A Tucker
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

4.  Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA.

Authors:  Walter E Pofahl; Claudia E Goettler; Keith M Ramsey; M Kathy Cochran; Delores L Nobles; Michael F Rotondo
Journal:  J Am Coll Surg       Date:  2009-03-26       Impact factor: 6.113

5.  Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens.

Authors:  Angela S Rossney; Celine M Herra; Gráinne I Brennan; Pamela M Morgan; Brian O'Connell
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

6.  Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares.

Authors:  D M Wolk; E Picton; D Johnson; T Davis; P Pancholi; C C Ginocchio; S Finegold; D F Welch; M de Boer; D Fuller; M C Solomon; B Rogers; M S Mehta; L R Peterson
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

7.  Evaluation of the Copan ESwab transport system for the detection of methicillin-resistant Staphylococcus aureus: a laboratory and clinical study.

Authors:  Annick Smismans; Jan Verhaegen; Annette Schuermans; Johan Frans
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

8.  Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery.

Authors:  S Jog; R Cunningham; S Cooper; M Wallis; A Marchbank; P Vasco-Knight; P J Jenks
Journal:  J Hosp Infect       Date:  2008-04-02       Impact factor: 3.926

Review 9.  Rapid methods for detection of MRSA in clinical specimens.

Authors:  Elizabeth L Palavecino
Journal:  Methods Mol Biol       Date:  2014

10.  Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.

Authors:  Eili Klein; David L Smith; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883
View more
  6 in total

1.  Evaluation of the BD Max MRSA XT assay for use with different swab types.

Authors:  Alexander H Dalpke; Marjeta Hofko; Christian Stock; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

2.  Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.

Authors:  Melanie L Yarbrough; David K Warren; Karen Allen; Dennis Burkholder; Robert Daum; Curtis Donskey; Dennis Knaack; Anthony LaMarca; Larissa May; Loren G Miller; David M Parenti; Lance Peterson; Thean Yen Tan; Raymond Widen; Diana R Hernandez; Donna M Wolk; C A Burnham
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

3.  Evaluation of BD Max StaphSR and BD Max MRSAXT Assays Using ESwab-Collected Specimens.

Authors:  Suzane Silbert; Carly Kubasek; Faris Galambo; Elaine Vendrone; Raymond Widen
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

4.  Detection of Group B Streptococcus Directly from Collected ESwab Samples by Use of the BD Max GBS Assay.

Authors:  Suzane Silbert; Talita T Rocchetti; Alicia Gostnell; Carly Kubasek; Raymond Widen
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

5.  Comparison of ESwab and Wound Fiber Swab Specimen Collection Devices for Use with Xpert SA Nasal Complete Assay.

Authors:  Eric T Beck; Blake W Buchan; Garrett C Reymann; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2016-04-27       Impact factor: 5.948

6.  Comparison of the Copan eSwab System with an Agar Swab Transport System for Maintenance of Fastidious Anaerobic Bacterium Viability.

Authors:  Kerin L Tyrrell; Diane M Citron; Eliza S Leoncio; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.